Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 12 of 12 entries
View as:

A Phase I SAD and MAD Clinical Trial of CNM-Au8 in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02755870 Org: User:
Start: 04/30/15 End: 10/31/16 Due: 10/31/17

Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT03536559 Org: User:
Start: 11/23/18 End: 07/12/22 Due: 07/12/23

Therapeutic Nanocatalysis to Slow Disease Progression of Amyotrophic Lateral Sclerosis (ALS)

Phase: N/A Priority: Normal
NCT ID: NCT04098406 Org: User:
Start: 12/19/19 End: 07/13/21 Due: 07/13/22

Two Intermediate Expanded Access Protocols (EAP) CNMAu8.EAP01 and CNMAu8.EAP02 for ALS

Phase: N/A Priority: Normal
NCT ID: NCT05281484 Org: User:
Start: - End: - Due: -

Intermediate Expanded Access Protocol CNMAu8.EAP03

Phase: N/A Priority: Normal
NCT ID: NCT04081714 Org: User:
Start: - End: - Due: -

A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT04626921 Org: User:
Start: 10/22/20 End: 09/06/23 Due: 09/06/24

31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03815916 Org: User:
Start: 12/19/19 End: 06/07/21 Due: 06/07/22

An Open-Label Extension for the Phase 2 Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients on Stable Background Therapy to Assess Bioenergetic Catalysis With CNM-Au8 to Slow Disease Progression in ALS

Phase: N/A Priority: Normal
NCT ID: NCT05299658 Org: User:
Start: 11/13/21 End: 08/31/25 Due: 08/31/26

Study of ZnAg Liquid Solution to Treat COVID-19 Symptomatic Participants

Phase: N/A Priority: Normal
NCT ID: NCT04610138 Org: User:
Start: 06/01/21 End: 10/20/22 Due: 10/20/23

31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Multiple Sclerosis.

Phase: N/A Priority: Normal
NCT ID: NCT03993171 Org: User:
Start: 12/19/19 End: 06/30/25 Due: 06/30/26

31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Amyotrophic Lateral Sclerosis (REPAIR-ALS)

Phase: N/A Priority: Normal
NCT ID: NCT03843710 Org: User:
Start: 03/31/20 End: 03/31/22 Due: 03/31/23

Intermediate Expanded Access Protocol CNMAu8.EAP04

Phase: N/A Priority: Normal
NCT ID: NCT06408727 Org: User:
Start: - End: - Due: -